It’s understood that around 6,000 patients could benefit from this.
The Irish Patients Association today welcomes the agreement reached between the State and the Irish Pharmaceutical Healthcare Association for a four-year medicines deal, expected to be approved by the Government.
According to Chair of the Irish Patients Association, Stephen McMahon said "This agreement addresses an unconscionable two-tier system where private patients access new cancer treatments up to two years before public patients can access the same medicine through the HSE."
For cancer medicines, it would cut delays by 514 days from the current 694-day average.
The agreement appropriately balances patients' rights to equitable access and innovation with the State's responsibility to ensure cost-effectiveness within finite health budgets.
Approximately 32 new medicines are expected this year, covering treatments for cancer, diabetes, and heart disease.
It’s understood that around 6,000 patients could benefit from this.
Water Outage In Place For Maynooth And Straffan Tomorrow
Kfm Obituary Notices
Nationwide Fuel Protest Continues Into Third Day
"I Don't Think Anybody Is Going To Really Listen To Us Until Somebody Dies On That Road": Criticism Of Moone-Timolin Cycleway Continues
International Wholesale Prices Are "Not Price Gouging", Says CCPC
Costs Of Home Heating Oil Up By 67.5 Per Cent Between February and March
91-Year-Old Lelia Doolan To Arrive In Monasterevin Today As Part Of Her Walk For Peace
Over €400,000 Awarded To Repair And Protect Three Kildare Heritage Structures
